Corrigendum: Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.
作者信息
Yin Xuejiao, Chen Lei, Fan Fengjuan, Yan Han, Zhang Yuyang, Huang Zhenli, Sun Chunyan, Hu Yu
机构信息
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, Wuhan, China.
出版信息
Front Oncol. 2021 Feb 18;11:657016. doi: 10.3389/fonc.2021.657016. eCollection 2021.
Abstract
[This corrects the article DOI: 10.3389/fonc.2020.01712.].
摘要
相似文献
1
Corrigendum: Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.
Front Oncol. 2021 Feb 18;11:657016. doi: 10.3389/fonc.2021.657016. eCollection 2021.
2
Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.华氏巨球蛋白血症的发病率和死亡率趋势：一项基于人群的研究。
Front Oncol. 2020 Sep 10;10:1712. doi: 10.3389/fonc.2020.01712. eCollection 2020.
3
Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database.华氏巨球蛋白血症患者继发恶性肿瘤的发病率：对 SEER 数据库的分析。
Cancer. 2015 Jul 1;121(13):2230-6. doi: 10.1002/cncr.29334. Epub 2015 Mar 10.
4
Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database.华氏巨球蛋白血症的生存趋势：监测、流行病学和最终结果数据库分析
Blood. 2014 Jun 19;123(25):3999-4000. doi: 10.1182/blood-2014-05-574871.
5
Corrigendum: Clinical characteristics and prognosis of patients with pulmonary mucoepidermoid carcinoma: a SEER-based analysis.勘误：肺黏液表皮样癌患者的临床特征与预后：一项基于监测、流行病学和最终结果（SEER）数据库的分析
Front Oncol. 2024 Sep 13;14:1486678. doi: 10.3389/fonc.2024.1486678. eCollection 2024.
6
Waldenström macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005.华氏巨球蛋白血症：一项对1988年至2005年监测、流行病学和最终结果数据库的回顾
Leuk Lymphoma. 2012 Aug;53(8):1625-6. doi: 10.3109/10428194.2012.656103. Epub 2012 Feb 13.
7
Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database.华氏巨球蛋白血症患者的总生存期和死亡的竞争风险：监测、流行病学和最终结果数据库分析
Br J Haematol. 2015 Apr;169(1):81-9. doi: 10.1111/bjh.13264. Epub 2014 Dec 18.
8
Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status.双重靶向NAMPT和BTK可协同杀伤华氏巨球蛋白血症细胞，无论MYD88和CXCR4体细胞突变状态如何。
Clin Cancer Res. 2016 Dec 15;22(24):6099-6109. doi: 10.1158/1078-0432.CCR-16-0630. Epub 2016 Jun 10.
9
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.瓦尔登斯特伦巨球蛋白血症或意义未明的单克隆免疫球蛋白血症患者的体细胞突变模式。
Haematologica. 2017 Dec;102(12):2077-2085. doi: 10.3324/haematol.2017.172718. Epub 2017 Oct 5.
10
Incidence of Waldenström's macroglobulinemia.
Blood. 1993 Nov 15;82(10):3148-50.
Zotero 插件